Heterozygote Advantage of the Type II Deiodinase Thr92Ala Polymorphism on Intrahospital Mortality of COVID-19.
de Lima Beltrão FE, de Almeida Beltrão DC, Carvalhal G, de Lima Beltrão FE, de Souza Braga Filho J, de Brito Oliveira J, de Jesus JDS, Machado GJR, Dos Santos Silva H, Teixeira HMP, Rodrigues JL, de Figueiredo CAV, Dos Santos Costa R, Hecht F, Bianco AC, da Conceição Rodrigues Gonçalves M, Ramos HE.
de Lima Beltrão FE, et al. Among authors: ramos he.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2488-e2501. doi: 10.1210/clinem/dgac075.
J Clin Endocrinol Metab. 2022.
PMID: 35137147
Free PMC article.